TDC
LFMD icon

Thompson Davis & Co’s LifeMD LFMD Stock Holding History

Thompson Davis & Co’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,000
Closed -$59.4K – 145
2024
Q4 		$59.4K Sell
12,000
-16,100
-57% -$84.4K 0.04% 114
2024
Q3 		$147K Sell
28,100
-12,150
-30% -$70.1K 0.11% 106
2024
Q2 		$276K Buy
40,250
+250
+0.6% +$2.29K 0.24% 77
2024
Q1 		$411K Buy
40,000
+25,855
+183% +$191K 0.28% 49
2023
Q4 		$117K Buy
+14,145
New +$102K 0.1% 85

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Thompson Davis & Co's LFMD Position: Q1 2025 in Review

Thompson Davis & Co sold out of LifeMD (LFMD) in Q1 2025, closing a stake of 12,000 shares — an estimated $59.4K sold.

Thompson Davis & Co first reported a position in LFMD in Q4 2023 and held it in 5 quarters. The position peaked at $411K in Q1 2024. 103 funds tracked by Wall St. Rank hold LFMD as of Q1 2025.

  • Thompson Davis & Co reported no remaining LifeMD position as of Q1 2025 after selling out during the quarter.
  • Thompson Davis & Co sold 12,000 LifeMD shares in Q1 2025, an estimated $59.4K.
  • Thompson Davis & Co first reported a position in LifeMD in Q4 2023 and held it in 5 quarters.
  • Thompson Davis & Co's LifeMD position peaked at $411K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held LifeMD as of Q1 2025.

Based on Thompson Davis & Co's 13F filing for Q1 2025, filed 13 May 2025.